Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Spitler

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Cancer|April 1, 1981
Serum copper and zinc levels in melanoma patientsG L Fisher, L E Spitler, K L McNeill, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1970
Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factorA S Levin, L E Spitler, D P Stites, et al.
Cancer|April 15, 1988
A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanomaL L Miller, L E Spitler, R E Allen, et al.
British Journal of Haematology|February 1, 1975
Phagocytes and C4 in paraproteinaemiaL E Spitler, P Spath, L Petz, et al.
The Journal of Experimental Medicine|July 1, 1972
Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease productionL E Spitler, C M Von Muller, H H Fudenberg, et al.
Cancer Research|March 1, 1987
Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in ratsS Harkonen, J Stoudemire, R Mischak, et al.
JAMA|August 22, 1977
Treatment of Bechçet's syndrome with transfer factorR E Wolf, H H Fudenberg, T M Welch, et al.
Cellular Immunology|October 1, 1975
The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family membersL E Spitler, A S Levin, D P Stites, et al.
Clinical Nephrology|January 1, 1975
Renal lesions accompanying poison oak dermatitisK B Devich, J C Lee, W L Epstein, et al.
Haematology and Blood Transfusion|January 1, 1978
[Resistance deficiency in multiple myeloma]P Spath, F Schmalzl, L E Spitler, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Cancer|April 1, 1981
Serum copper and zinc levels in melanoma patientsG L Fisher, L E Spitler, K L McNeill, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1970
Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factorA S Levin, L E Spitler, D P Stites, et al.
Cancer|April 15, 1988
A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanomaL L Miller, L E Spitler, R E Allen, et al.
British Journal of Haematology|February 1, 1975
Phagocytes and C4 in paraproteinaemiaL E Spitler, P Spath, L Petz, et al.
The Journal of Experimental Medicine|July 1, 1972
Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease productionL E Spitler, C M Von Muller, H H Fudenberg, et al.
Cancer Research|March 1, 1987
Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in ratsS Harkonen, J Stoudemire, R Mischak, et al.
JAMA|August 22, 1977
Treatment of Bechçet's syndrome with transfer factorR E Wolf, H H Fudenberg, T M Welch, et al.
Cellular Immunology|October 1, 1975
The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family membersL E Spitler, A S Levin, D P Stites, et al.
Clinical Nephrology|January 1, 1975
Renal lesions accompanying poison oak dermatitisK B Devich, J C Lee, W L Epstein, et al.
Haematology and Blood Transfusion|January 1, 1978
[Resistance deficiency in multiple myeloma]P Spath, F Schmalzl, L E Spitler, et al.
Pageof 9